B lymphocytes as effector cells in the immunotherapy of cancer. - Wikidata - awgldk - TriplyDB

B lymphocytes as effector cells in the immunotherapy of cancer.

B lymphocytes as effector cells in the immunotherapy of cancer.

http://www.wikidata.org/entity/Q37928542

about

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.GIFT4 fusokine converts leukemic B cells into immune helper cells The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.

P2860

Q30299957-DE76CEBF-436D-4EB4-9419-A2F8D7BC8C18 Q36629387-A878697C-58A1-4F81-8530-A8AEFFE95C8B Q36842259-C14BBC36-D971-4725-9479-94617EDF6E33 Q38819757-94FC28E7-28B0-48D3-8D6A-787390B64FE3 Q40056727-7EAD4367-E255-44E6-B2D2-4998D66A9D8A Q47300233-F1B3547F-1AA6-497D-9FF9-B1A306EEC354 Q54219261-2800A475-61BC-4BC8-9918-4A74EE9E34FA

P2860

B lymphocytes as effector cells in the immunotherapy of cancer.

http://www.wikidata.org/entity/Q37928542

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

B lymphocytes as effector cells in the immunotherapy of cancer.

@en

B lymphocytes as effector cells in the immunotherapy of cancer.

@nl

type

label

B lymphocytes as effector cells in the immunotherapy of cancer.

@en

B lymphocytes as effector cells in the immunotherapy of cancer.

@nl

prefLabel

B lymphocytes as effector cells in the immunotherapy of cancer.

@en

B lymphocytes as effector cells in the immunotherapy of cancer.

@nl

P1433

Q37928542-7D44DC07-11DF-4813-93E8-5B9E5B92A74B

P1476

Q37928542-011963CE-E4AA-4EC5-983C-4AE486B77A0C

P2093

Q37928542-2AD0099B-647F-47A5-A289-A8618569784D

Q37928542-2C846260-975C-47C0-BE78-F4DB45A959C7

Q37928542-3DE27C5F-3B0C-4321-B983-52A9C62A7AE9

Q37928542-6904E5E9-7EE6-482A-8225-2ECB41B77EA8

Q37928542-B288AD14-C046-496B-9EF1-874BF7A4E6AF

Q37928542-C1A5AB0C-23A9-459E-805C-8094E9731769

Q37928542-CB5D90BE-E78E-44B6-B655-8DA371B21456

Q37928542-D55598B3-A523-4E94-AC92-4640F340697B

Q37928542-E33CBDA1-0485-4308-A8E7-FEBAEB29D9E1

P2860

Q37928542-026D026A-7BCD-4ACE-8381-C5863CDCBCF1

Q37928542-06AB3FBF-B9EB-428E-8A69-97F0ECA5BC9C

Q37928542-1037A339-8E89-4BB7-908E-E6FD7134F8E0

Q37928542-18C1828A-F5BB-4B7F-B5D9-B044CA9224FC

Q37928542-1FD434EE-9BA8-45B7-8979-EF51FE7468EB

Q37928542-22AA84E4-BBF8-4642-AB47-E2A7B63D3F5B

Q37928542-261126D8-1A9E-4F0F-89D1-1198AF5CBE33

Q37928542-3343FC51-B080-4011-8A6C-21E84F87E95A

Q37928542-34464E58-A37C-4DED-A982-B0727B93CBF3

Q37928542-3A0B39AC-584A-472F-95A5-C91EFA209E1D

P304

Q37928542-E6112517-E43B-4C3D-83CA-21B9ABB1DAFC

P31

Q37928542-B6508526-2DCF-476B-9B66-7E232DE25011

P356

Q37928542-B397D0A7-9EBB-4B37-981A-5C34C509EDD0

P433

Q37928542-E1ADCE2F-E13E-40F5-8A1B-9C9CA440C71E

P478

Q37928542-3786DC6E-C4A2-412A-BE49-924E76DEBBBA

P577

Q37928542-1F18079D-78B7-44B1-8000-C7AC96038F04

P698

Q37928542-5776044E-9EEF-406D-BCA8-09E7F5E19D40

P921

Q37928542-7095DA98-D117-4D9F-99AC-49633A8301AC

P932

Q37928542-40DDADCC-40D9-4366-BDAB-27D6C02EA725

P356

P1433

Journal of Surgical Oncology

P1476

B lymphocytes as effector cells in the immunotherapy of cancer.

@en

P2093

Alfred E Chang

http://www.w3.org/2001/XMLSchema#string

David M Lubman

http://www.w3.org/2001/XMLSchema#string

Jianhui Zhu

http://www.w3.org/2001/XMLSchema#string

Jintang He

http://www.w3.org/2001/XMLSchema#string

Jukes P Namm

http://www.w3.org/2001/XMLSchema#string

Qiao Li

http://www.w3.org/2001/XMLSchema#string

Shuang Wei

http://www.w3.org/2001/XMLSchema#string

Xiangming Lao

http://www.w3.org/2001/XMLSchema#string

Yashu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The functions of the thymus system and the bursa system in the chicken

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

B lymphocytes: how they develop and function.

Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression

A case for regulatory B cells.

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.

In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.

P304

431-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.22093

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21898417

http://www.w3.org/2001/XMLSchema#string

P921

P932

4315332

http://www.w3.org/2001/XMLSchema#string